Companion Diagnostics
News on companion diagnostics and drug/test co-development.
Qiagen highlighted new products for biopharma, next-generation sequencing, and sample prep at AACR this week.
EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage
The real-time PCR-based companion diagnostic test identifies patients eligible for treatment with Amgen's Vectibix (panitumumab).
Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.
Pillar Biosciences Receives CMS Coverage for Pan-Cancer CDx Assay
The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.
Invivoscribe Acute Myeloid Leukemia Assay Nabs Regulatory Compliance in UK, Switzerland
The test detects FLT3 mutations, which are associated with poor prognosis in acute myeloid leukemia patients.